Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Occlusion

Dong-Bo Liu1, Bing-Xian Zhang1, Yao Zhou1

  • 1Department of Neurology, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou, Henan, China.

Insights

A low ankle-brachial index (ABI) may predict a higher risk of acute ischemic cerebrovascular events (AICE) after central retinal artery occlusion (CRAO). This simple test can help identify patients needing closer stroke prevention strategies.

Area of Science:

  • Vascular Neurology
  • Ophthalmology
  • Cardiology

Background:

  • Identifying patients at high risk for acute ischemic cerebrovascular events (AICE) after central retinal artery occlusion (CRAO) is vital for stroke prevention.
  • The ankle-brachial index (ABI) is a non-invasive measure of peripheral artery disease.

Purpose of the Study:

  • To investigate the association between a low ankle-brachial index (ABI) and the risk of AICE in patients with CRAO.
  • To determine if ABI can serve as a predictor for secondary stroke prevention in CRAO patients.

Main Methods:

  • Prospective analysis of 335 patients admitted for CRAO between February 2019 and March 2023.
  • Patients were categorized based on ABI: low (≤0.90) versus normal (0.91-1.40).
  • Association between ABI and AICE (ischemic stroke or TIA) within 1 year was analyzed using univariable and multivariable logistic regression.

Main Results:

  • Of 335 patients, 110 (32.8%) had a low ABI, and 89 (26.6%) experienced AICE within 1 year.
  • Patients with a low ABI had a significantly higher incidence of AICE (36.4%) compared to those with a normal ABI (21.8%, P<0.01).
  • Low ABI was identified as an independent predictor of AICE after CRAO (OR 1.864, P=0.022).

Conclusions:

  • Low ankle-brachial index values independently predict an increased risk of acute ischemic cerebrovascular events following central retinal artery occlusion.
  • The ABI may function as a valuable, non-invasive screening tool for identifying CRAO patients who require intensified secondary stroke prevention efforts.